Cutaneous T-cell Lymphoma of the Mycosis Fungoides Variant: A Case Report. [PDF]
Dominguez Sánchez CM +1 more
europepmc +1 more source
Colonic anaplastic soft tissue sarcoma in a western hognose snake (Heterodon nasicus)
Abstract Neoplastic disease is increasingly being recognized in snakes as a cause of morbidity, with gastrointestinal neoplasms being commonly reported. However, clinical signs are often non‐specific making diagnosis challenging. This case describes the first report of a colonic anaplastic soft tissue sarcoma in a western hognose snake (Heterodon ...
Colin Clarke +4 more
wiley +1 more source
Case Report: Dermoscopic and pathologic features of primary cutaneous follicle center lymphoma involving the nasal ala. [PDF]
Han Y, Zhao SN, Wang X, Zheng S.
europepmc +1 more source
Long‐term survival after surgical removal of an intermediate grade pancreatic carcinoma in a cat
Abstract An 11‐year‐old male neutered domestic shorthair cat presented with a history of acute diarrhoea, decreased appetite, and a palpable abdominal mass. Following clinical staging and histopathological examination after partial pancreatectomy, the cat was diagnosed with a completely excised intermediate grade pancreatic carcinoma without evidence ...
Abel Verbrugghe +4 more
wiley +1 more source
Cutaneous T-cell lymphoma and dupilumab for atopic dermatitis: Practical guidance for a clinical conundrum. [PDF]
De Benedetto A, Mannava KA.
europepmc +1 more source
Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz +22 more
wiley +1 more source
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley +1 more source
Cutaneous T Cell Lymphoma: Targeting the Survival Network in Mycosis Fungoides and Sézary Syndrome. [PDF]
Heumann P +5 more
europepmc +1 more source
New Treatment Strategy and Future Research Direction for BRAF‐Mutated Cancer
Treatment with BRAF inhibitor plus MEK inhibitor is currently used in BRAF‐mutated various malignancies except colorectal cancer, and treatments with BRAF and/or MEK inhibitors and anti‐EGFR antibody are used in BRAF‐mutated colorectal cancer. Despite recent advances in BRAF‐targeted therapies, their efficacy is still limited.
Masanobu Takahashi +2 more
wiley +1 more source

